RenoVate Therapeutics

Regenerative Kidney Therapeutics

Health Tech & Life Sciences

Active

Seed Founded 2022

Website ↗ LinkedIn

Total raised

—

Last: Undisclosed 2022-03

Stage

Seed

Founded

2022

Headcount

—

Sector

Health Tech & Life Sciences

About

RenoVate Therapeutics is developing regenerative biomolecules designed to repair and rejuvenate the kidneys. The regenerative biomolecules are derived from cells expanded from the patient’s own urine using proprietary technology.

Funding history · 1 round · — total

2022-03

Undisclosed Undisclosed

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development

Technologies

BiologicalsCells

Target customers

Healthcare & Life SciencesHealthcareProvidersPatientsLife SciencesBiotechnology

Business model

B2C

Name	RenoVate Therapeutics
Slug	renovate-therapeutics
Type	Israeli Startup
Founded	2022
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object], [object Object]
Business models	B2C
Target customers	[object Object], [object Object], [object Object], [object Object], [object Object], [object Object]
Status	active
Current stage	Seed
Public stage	Seed
Total raised (USD)	0
Last round	Undisclosed (2022-03)
Website	https://www.renovate.bio
Israeli Companies Registrar	516566841

Name	Role	LinkedIn
David C.
Tobias Huber
Benjamin Dekel
Daniel Clayman
Dorit Omer
Keren Souffir
Pierre Ronco

RenoVate Therapeutics

About

Funding history · 1 round · — total

Sectors & technology

Tags